Chembio Diagnostics (CEMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2009 | 12-2008 | 09-2008 | 06-2008 | 03-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -325 | -1,949 | -1,398 | -1,161 | -798 |
| Depreciation Amortization | 99 | 345 | 239 | 154 | 76 |
| Accounts receivable | 187 | 137 | -1,075 | -489 | -23 |
| Other Working Capital | 445 | 117 | -554 | -807 | -342 |
| Other Operating Activity | -170 | 155 | 1,344 | 734 | 213 |
| Operating Cash Flow | $236 | $-1,194 | $-1,445 | $-1,570 | $-874 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -151 | -398 | -364 | -289 | -179 |
| Investing Cash Flow | $-151 | $-398 | $-364 | $-289 | $-179 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -5 | -24 | -19 | -14 | -9 |
| Financing Cash Flow | $-5 | $-24 | $-19 | $-14 | $-9 |
| Beginning Cash Position | 1,212 | 2,827 | 2,827 | 2,827 | 2,827 |
| End Cash Position | 1,292 | 1,212 | 999 | 954 | 1,765 |
| Net Cash Flow | $80 | $-1,615 | $-1,828 | $-1,873 | $-1,063 |
| Free Cash Flow | |||||
| Operating Cash Flow | 236 | -1,194 | -1,445 | -1,570 | -874 |
| Capital Expenditure | -151 | -398 | -364 | -289 | -179 |
| Free Cash Flow | 85 | -1,592 | -1,809 | -1,859 | -1,053 |